Common Contracts
3 similar License and Collaboration Agreement contracts by Medicines Co /De
Development and marketing agreement for ALN-PCS RNAi therapeutic programLicense and Collaboration Agreement • February 8th, 2022 • New York
Milestones, US$m: 180 : sum of potential development and commercial milestone payments n/d : scaled double-digit royalties on global products sales of ALN-PCS
LICENSE AND COLLABORATION AGREEMENT by and between ALNYLAM PHARMACEUTICALS, INC. and THE MEDICINES COMPANYLicense and Collaboration Agreement • July 25th, 2013 • Medicines Co /De • Pharmaceutical preparations • New York
THIS LICENSE AND COLLABORATION AGREEMENT (this “Agreement”), effective as of February 3, 2013 (the “Effective Date”), by and between Alnylam Pharmaceuticals, Inc., a corporation organized and existing under the laws of the State of Delaware (“Alnylam”) and, The Medicines Company, a corporation organized and existing under the laws of Delaware (“MedCo”).
LICENSE AND COLLABORATION AGREEMENT by and between ALNYLAM PHARMACEUTICALS, INC. and THE MEDICINES COMPANYLicense and Collaboration Agreement • May 10th, 2013 • Medicines Co /De • Pharmaceutical preparations • New York
THIS LICENSE AND COLLABORATION AGREEMENT (this “Agreement”), effective as of February 3, 2013 (the “Effective Date”), by and between Alnylam Pharmaceuticals, Inc., a corporation organized and existing under the laws of the State of Delaware (“Alnylam”) and, The Medicines Company, a corporation organized and existing under the laws of Delaware (“MedCo”).
